CureMatch Articles & News
Jessica Federer Joins Advisory Board to Advance Cancer Cures. Stephane Richard and Jessica Federer to speak at PMLS2018. SAN DIEGO, CA – June 26, 2018 – CureMatch, Inc., a digital precision oncology company bridging the gap between legacy cancer treatments and advances in personalized medicine, announces the addition of Jessica Federer to its advisory board. Ms. […]
SAN DIEGO, CA – June 22, 2018 – CureMatch, Inc. offers results of an artificial intelligence (AI) based cancer study at the WIN Symposium 2018 in Paris, June 25-26. CureMatch Co-founder Razelle Kurzrock, M.D. is the Organizing Committee Co-Chair of this 10th anniversary Worldwide Innovative Networking in Personalized Cancer Research event. CureMatch data scientist, Alexander […]
SAN DIEGO, CA – June 14, 2018: CureMatch wins Metroconnect startup pitchfest. Global expansion to include Center for Oncology in Pediatrics (COP) in Mexico. A $35,000 grant will support foreign market expansion of CureMatch precision oncology technology to improve cancer treatment outcomes around the globe.
SAN DIEGO – June 8, 2018, World Trade Center San Diego and a live voting audience awarded $35K to local digital health oncology company CureMatch, as part of the MetroConnect Grand Prize PitchFest. Thank you to World Trade Center San Diego, and the grant awarded by JPMorgan Chase & Co. The real winners are those around the world benefiting from CureMatch's continued innovation and technology in Precision Medicine developed specifically to help oncology professionals find the best cancer treatments.
When it comes to cancer treatment in Mexico, just like in the United States, many cancer patients and their doctors still rely on traditional “one-size-fits-all” methods of care. CureMatch is looking to extend Precision Medicine technology to doctors and facilities responsible for any cancer treatment in Mexico.